BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6340756)

  • 21. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
    Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
    Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.
    Johnson FL; Thomas ED; Clark BS; Chard RL; Hartmann JR; Storb R
    N Engl J Med; 1981 Oct; 305(15):846-51. PubMed ID: 7024804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
    Barrett AJ; Joshi R; Tew C
    Lancet; 1985 May; 1(8439):1188-91. PubMed ID: 2860389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
    Coccia PF; Strandjord SE; Warkentin PI; Cheung NK; Gordon EM; Novak LJ; Shina DC; Herzig RH
    Blood; 1988 Apr; 71(4):888-93. PubMed ID: 3281725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission.
    Torres A; Martínez F; Gómez P; Fornés G; Rojas R; Herrera C; Gómez JL; Manzanares R; García JM; Andres P
    Bone Marrow Transplant; 1989 Nov; 4(6):609-12. PubMed ID: 2819281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse.
    Bordigoni P; Vernant JP; Souillet G; Gluckman E; Marininchi D; Milpied N; Fischer A; Benz Lemoine E; Jouet JP; Reiffers J
    J Clin Oncol; 1989 Jun; 7(6):747-53. PubMed ID: 2654331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
    N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
    Steinherz PG; Gaynon P; Miller DR; Reaman G; Bleyer A; Finklestein J; Evans RG; Meyers P; Steinherz LJ; Sather H
    J Clin Oncol; 1986 May; 4(5):744-52. PubMed ID: 3517244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.
    Neudorf S; Sanders J; Kobrinsky N; Alonzo TA; Buxton AB; Gold S; Barnard DR; Wallace JD; Kalousek D; Lange BJ; Woods WG
    Blood; 2004 May; 103(10):3655-61. PubMed ID: 14751924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
    Meyers JD; Flournoy N; Sanders JE; McGuffin RW; Newton BA; Fisher LD; Lum LG; Appelbaum FR; Doney K; Sullivan KM
    Ann Intern Med; 1987 Dec; 107(6):809-16. PubMed ID: 2825571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R; Gale RP
    Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.
    Bostrom B; Brunning RD; McGlave P; Ramsay N; Nesbit M; Woods WG; Hurd D; Krivit W; Kim T; Goldman A
    Blood; 1985 May; 65(5):1191-6. PubMed ID: 3888309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Soiffer RJ; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman RL; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
    Blood; 1997 Apr; 89(8):3039-47. PubMed ID: 9108425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
    Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.